FDA Investigator Joanne M Schlossin

Joanne M Schlossin has inspections in 14 countries as of 21 Dec 2023. Joanne M Schlossin has collaborated with a combinined 3864 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
214
Last Inspection Date:
21 Dec 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America, Netherlands, India, Czechia, China, Italy, Germany, Switzerland, France, Romania, United Kingdom of Great Britain and Northern Ireland, Canada, Australia, El Salvador
Co-Investigator(s):
Ademola O Daramola, Akbar J Zaidi, Althea A Williams, Alyssa R Favro, Amanda E Lewin, PhD, Andrea A Branche, Andrew B Paglia, DPM, Andrew M Abramowitz, Anh M Lac, Anissa M Vargas, Ann B Okon, Anthony A Charity, Anthony J Grace, Arduino Frankovic, Arnold Seo, PhD, Arthur G Hurst, Audrey J Yarbrough, Azza Talaat, Barbara J Rincon, Benton M Ketron, Betsy C Galliher, Bonnie L Fry, Bonnie L Menzel, Brandy N Lepage, Bruce G Cooper, Byungja E Marciante, Camille D Brown, Carmen Y Fisher, Charles D Brown, Charles R Bonapace, PhD, Cheron M Portee, Chilton, Chmura, Christopher D Rush, Christopher J Smith, Christopher S Fields, Clinton V Giustra, Crystal A Branch, Cynthia A Harris, MD, RN, Daniel J Lahar, Daniel L Aisen, David A Carlson, David M Beltran, David M Mcnew, Dawn C Olenjack, Denise L Burosh, Diamond M Oden, Diane E Bruce, Dipesh K Shah, Donald J Ullstrom, Dr. Abhijit Raha, PhD, Dr. Gopa Biswas, PhD, Dr. Mark J Seaton, PhD, Dr. Sriram Subramaniam, PhD, Dr. Zhou Chen (nmi), MD PhD, Dustin P Tran, Elisa M Fleming, Elizabeth D Connell, Elizabeth H Davis, Elizabeth H Slazak, Erin L Nagel, Farhana Khan, Felix Maldonado, Gabriel Davila, Gajendiran Mahadevan, PhD, Gary T Greco, Gene R Gunn, George C Amedro, Gulshan R Anand, Habacuc V Barrera, Hamet Toure, PharmD MPH, Harry J Brewer, Hilary K Wagner, Hugh M Mcclure, II, Ingrid A Zambrana, Iram R Hassan, PhD, Irina Gaberman, Iris C Macinnes, Jackson Y See, James D Bridges, James M Kewley, Jane Chen, Janete F Guardia, Jay T Wong, Jeanette L Mcginnis, Joel D Martinez, Joel R Merriman, Jogy George, John A Gonzalez, John A Podsadowski, Jonathan D Green, Joseph A Famiglietti, Joseph J Vannelli, Joshua C Schafer, Joshua D Lopez, Joy P Matthias, Joyce A Williams, Judy Keihl, Julie Scoma, Karen L Kosar, Kathryn A Nagy, Kathryn Suttling, Kelly N Kerr, Kenneth G Klobus, Kent C Faul, Kerun Hardeo, Kham Phommachanh, Kim M Downing, Kimberley A Ricketts, Kimberly Y Smithson, Kyle J Spencer, Ladislav Kermet, Lance M De Souza, MBA, Lata C Mathew, PhD, Latorie S Jones, Laura E Garcia, Lauren E Blaser, LCDR Chad N Thompson, Leon L Crawley, Li Hongpaul Yeh, PhD, Linda Galindo, Linda M Moore, Linda M Sacco, Lisa A Doyle, Lourdes Andujar, Madushini Dharmasena, PhD, Makini Cobourne Duval, PhD, Marc S Neubauer, Margaret E Sarles, Margaret M Annes, Marijo B Kambere, PhD, Marilyn S Babu, Marlene L Davis, Martinez, Mary Alice B Garlipp, Mary M Finn, Matthew C Watson, Matthew D Schnittker, Melissa N Gregorio, Melkamu Getie Kebtie, PhD, Michael A Charles, Michael F Skelly, PhD, Michael G Sinkevich, Michael R Dominick, Michael W Burd, Michelle J Hines, Michelle M Noe Varga, Mindy M Chou, Mohsen Rajabi Abhari, FDA, Morris Paul, Mra Davism, Mra Narulaa, Muralidhara B Gavini, PhD, Nancy A Bellamy, Nancy G Schmidt, Nancy M Espinal, Nicholas C Mendiola, Nicholas L Paulin, Omadevi Somai, Investigator, Pamela L Vega, Pankaj H Amin, Parul M Patel, Patricia H Dlugosz, Paul A Bonneau, Paul Mouris, Pauline N Logan, Peter M Trunk, Philip M Steele, PhD, Phillip Angart, PhD, Phillip D Waldron, Randi Lynn Bodoh, Richard K Glabach, Richard W Berning, Robert C Steyert, Robert J Veitch, Robin R Waller, Robles, Ruben C Ayala, PharmD, Russ E Davis, Ruth E Medcalf, Sabine Francke, Sajin Bae, Samantha J Pinizzotto, D V M, Sasha M Latonis, Scott B Laufenberg, Scott T Ballard, Shannon A Dinardo, Simone E Pitts, Smith, Sony Mathews, Sripal R Mada, PhD, Stacey F Rivette, State Agency, Stefanie R Cook, Stephen L Beekman, Steven E Bowen, PhD, Steven J Libal, Stuart W Russell, Syeda N Mahazabin, Tammy S Notto, Tara K Carmody, Tara K Normandin, Terrance L Thomas, Terri E Gibson, Theressa B Smith, Thomas L Bellonte, Thomas P Hansen, Thomas W Gordon, Travis M Beard, Tricia S Martinez, Tyanna N Hadley, Vickie J Kanion, Wendy M Stone, William P Chilton, Xiaohan Cai, PhD, Xikui Chen (nmi), PhD, Yiyue Zhang (nmi), PhD

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more